Human Soluble gp130 Quantikine ELISA Kit
| Name | Human Soluble gp130 Quantikine ELISA Kit |
|---|---|
| Supplier | R&D Systems |
| Catalog | DGP00 |
| Category | ELISA Kit |
| Prices | $509.00 |
| Sizes | 1 kit |
| Assay Type | Solid Phase Sandwich ELISA |
| Sample Type | Cell Culture Supernates (100 uL), Serum (10 uL), EDTA Plasma (10 uL), Heparin Plasma (10 uL), Citrate Plasma (10 uL) |
| Sensitivity | 0.08 ng/mL |
| Range | 0.1 - 8 ng/mL (Cell Culture Supernates), 0.3 - 16 ng/mL (Serum, EDTA Plasma, Heparin Plasma, Citrate Plasma) |
| Format | 96-well strip plate |
| Applications | ELISA |
| Species Reactivities | Human |
| Description | The Quantikine Human soluble gp130 Immunoassay is a 4.5 or 5.5 hour solid phase ELISA designed to measure sgp130 in cell culture supernates, serum, and plasma |
| Gene | IL6ST |
| Supplier Page | Shop |
Product images
Product References
Serum soluble glycoprotein 130 concentration is inversely related to insulin - Serum soluble glycoprotein 130 concentration is inversely related to insulin
Nikolajuk A, Kowalska I, Karczewska-Kupczewska M, Adamska A, Otziomek E, Wolczynski S, Kinalska I, Gorska M, Straczkowski M. Diabetes. 2010 Apr;59(4):1026-9.
Maternal country of origin, breast milk characteristics and potential influences - Maternal country of origin, breast milk characteristics and potential influences
Holmlund U, Amoudruz P, Johansson MA, Haileselassie Y, Ongoiba A, Kayentao K, Traore B, Doumbo S, Schollin J, Doumbo O, Montgomery SM, Sverremark-Ekstrom E. Clin Exp Immunol. 2010 Dec;162(3):500-9.
Soluble and membrane levels of molecules involved in the interaction between - Soluble and membrane levels of molecules involved in the interaction between
Perez-Andres M, Almeida J, Martin-Ayuso M, De Las Heras N, Moro MJ, Martin-Nunez G, Galende J, Cuello R, Abuin I, Moreno I, Dominguez M, Hernandez J, Mateo G, San Miguel JF, Orfao A. Int J Cancer. 2009 Jan 15;124(2):367-75.
Functional characterization of a soluble gp130 isoform and its therapeutic - Functional characterization of a soluble gp130 isoform and its therapeutic
Richards PJ, Nowell MA, Horiuchi S, McLoughlin RM, Fielding CA, Grau S, Yamamoto N, Ehrmann M, Rose-John S, Williams AS, Topley N, Jones SA. Arthritis Rheum. 2006 May;54(5):1662-72.
Circulating interleukin-6 family cytokines and their receptors in patients with - Circulating interleukin-6 family cytokines and their receptors in patients with
Hirota H, Izumi M, Hamaguchi T, Sugiyama S, Murakami E, Kunisada K, Fujio Y, Oshima Y, Nakaoka Y, Yamauchi-Takihara K. Heart Vessels. 2004 Sep;19(5):237-41.
Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus - Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus
Lukashevich IS, Tikhonov I, Rodas JD, Zapata JC, Yang Y, Djavani M, Salvato MS. J Virol. 2003 Feb;77(3):1727-37.
Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances - Gp130 activation by soluble interleukin-6 receptor/interleukin-6 enhances
Erices A, Conget P, Rojas C, Minguell JJ. Exp Cell Res. 2002 Oct 15;280(1):24-32.
Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid - Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid
Stubner S, Schon T, Padberg F, Teipel SJ, Schwarz MJ, Haslinger A, Buch K, Dukoff R, Lasser R, Muller N, Sunderland T, Rapoport SI, Moller HJ, Hampel H. Neurosci Lett. 1999 Jan 15;259(3):145-8.
Discriminant power of combined cerebrospinal fluid tau protein and of the soluble - Discriminant power of combined cerebrospinal fluid tau protein and of the soluble
Hampel H, Teipel SJ, Padberg F, Haslinger A, Riemenschneider M, Schwarz MJ, Kotter HU, Scheloske M, Buch K, Stubner S, Dukoff R, Lasser R, Muller N, Sunderland T, Rapoport SI, Moller HJ. Brain Res. 1999 Mar 27;823(1-2):104-12.